搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Cystic Fibrosis Foundation
11 天
FDA Approves New, Once-a-Day CFTR Modulator for People With CF
A new CFTR modulator treatment called Alyftrek has been approved for people with CF ages 6 and older who have CFTR mutations ...
BlackDoctor
11 天
Living With Cystic Fibrosis: 5 Everyday Habits That Can Change It ALL
Whether you are dealing with severe consequences of cystic fibrosis or want to get ahead the symptoms, these tips will help.
FiercePharma
8 天
Vertex snags FDA nod for once-daily cystic fibrosis triplet Alyftrek as switch from ...
As Vertex Pharmaceuticals reels from a painful trial readout for its pain candidate suzetrigine, the Boston biotech has ...
8 天
Vertex wins approval for new once-daily CF drug
Vertex Pharmaceuticals Inc. notched two FDA victories late Friday for its cystic fibrosis medicines, increasing the number of ...
12 天
A Success Story: Digital Opinion Leader Analysis for Cystic Fibrosis Treatments | DelveInsight
Cystic fibrosis is a life-limiting autosomal recessive genetic disorder that primarily affects the lungs and digestive system ...
11 天
Vertex Announces US FDA Approval of ALYFTREK™, a Once-Daily Next-in-Class CFTR Modulator ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈